Sweden: IRRAS considers relisting in Stockholm

Kleanthis Xanthopoulos, president and chief executive of IRRAS

Brain surgery technology specialists IRRAS plans to relist its shares from Nasdaq First North Premier to Nasdaq Stockholm’s main market at some point this year. The Stockholm-based company has engaged Carnegie Investment Bank as financial advisor. “Applying for a listing of IRRAS’ shares to Nasdaq Stockholm’s main list has been a goal since we were first listed…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »